Leukemia Research
Volume 27, Issue 1 , Pages 5-12, January 2003

Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies

Bone Marrow Transplant Unit, Hematology Service, University Hospital La Fe, 46009 Valencia, Spain

Received 17 December 2001; accepted 9 April 2002.

Abstract 

Factors influencing the collection of autologous peripheral blood stem cells (PBSCs) were studied in 182 mobilization procedures performed on 145 consecutive patients with acute myeloblastic leukemia (AML; n=67) and with various non-myeloid malignancies (NMM; n=78). PBSC were collected following mobilization with chemotherapy, treatment with granulocyte colony-stimulating factor (G-CSF) or chemotherapy plus G-CSF. Fewer colony-forming unit granulocyte-macrophages (CFU-GMs) were collected from patients with AML than from patients with NMM (P<0.0001), although there were no differences in the numbers of CD34+ cells collected between both groups. Multiple regression analysis showed that chemotherapy alone was predictive of a low CD34+ yield in patients with NMM (regression coefficient (RC)=−2.1; P=0.003). In addition, the interactions “diagnosis mutliple myeloma (MM)×mobilization with chemotherapy” (RC=2.9; P=0.004) and “diagnosis MM×mobilization with chemotherapy plus G-CSF” (RC=2.1; P=0.04) also remained in the model, both showing a favorable influence. In AML, mobilization with chemotherapy plus G-CSF was associated with higher CD34+ yields (P=0.003). In this subgroup of patients, multiple regression analysis identified the number of cycles of previous chemotherapy (≤2 cycles; RC=1.3; P=0.03) and peripheral blood counts (WBC ≥1.5×109/l and monocytes >20%; RC=0.8; P=0.02) as the factors most predictive of CD34+ cell yield. These findings emphasize the need to optimize harvesting technique to enhance safety and minimize morbidity and costs of this valuable procedure.

Abbreviations:  AML, acute myeloblastic leukemia, BC, breast cancer, CFU-GM, colony-forming unit granulocyte-macrophage, HD, Hodgkin’s disease, HGF, hemopoietic growth factor, moAb, monoclonal antibody, MM, multiple myeloma, NHL, non-Hodgkin’s lymphoma, NMM, non-myeloid malignancies, PBSC, peripheral blood stem cell

Keywords:  Mobilization, Stem cells, Collection, Acute myeloid leukemia, Non-myeloid malignancies

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(02)00068-1

Leukemia Research
Volume 27, Issue 1 , Pages 5-12, January 2003